Table 1.
Summary of differences between risk classes.
| Class | Documentation | Notified body involved? | QMSa | Certificates | Clinical investigation |
| I (low risk) | Manufacturer must compile the technical documentation and self-declare conformity | No | Yes | No | Not mandatory. May be required depending on the outcome of the clinical evaluation |
| IIa (low-medium risk) | Manufacturer must draw up the technical documentation and apply to a European Notified Body | Yes | Yes, certified | Yes (Annex IX certificate, QMS certificate) | Not mandatory. May be required depending on the outcome of the clinical evaluation |
| IIb (medium-high risk) | Manufacturer must draw up the technical documentation and apply to a European Notified Body | Yes | Yes, certified | Yes (Annex IX certificate, QMS certificate) | Not mandatory. May be required depending on the outcome of the clinical evaluation |
| III (high risk) | Manufacturer must draw up the technical documentation and apply to a European Notified Body | Yes, expert panel | Yes, certified | Yes (Annex IX certificate, QMS certificate) | Mandatory |
aQMS: Quality Management System.